CINOXACIN supplier | CasNO.28657-80-9

Name
CINOXACIN
EINECS
CAS No. 28657-80-9
Article Data3
CAS DataBase
Density 1.64g/cm³
Solubility
Melting Point 261-262° (dec)
Formula C12H10 N2 O5
Boiling Point 517.2°Cat760mmHg
Molecular Weight 262.222
Flash Point 266.6°C
Transport Information
Appearance
Safety Moderately toxic by ingestion, subcutaneous and intravenous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NO_x.
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms 1-Ethyl-3-carboxy-6,7-methylenedioxy-4-cinnolone;Cinobac; Cinobactin; Cinoxacin; Compound 64716; NSC 304467; Noxigram; Uronorm
PSA 90.65000
LogP 0.84330

Synthetic route

: 74-96-4
ethyl bromide

: 90447-46-4
6,7-methylenedioxy-4(1H)-oxo-cinnolin-3-carboxylic acid ethylester

: 5137-55-3
Aliquat 336

: 28657-80-9
cinoxacin

Conditions

Conditions	Yield
With sodium hydroxide; potassium carbonate In water; toluene

...Expand

: 28657-80-9
cinoxacin

: sodium hexaflorophosphate

: 64-17-5
ethanol

: [Ru([9]aneS3)(dmso)3](PF6)2

: [Ru([9]aneS3)(dmso-κS)(cin-κ2O,O)](PF6)*EtOH

Conditions

Conditions	Yield
With sodium methylate In methanol for 2h; Reflux;	92.9%

...Expand

: 28657-80-9
cinoxacin

: nickel(II) sulfate heptahydrate

: 67-68-5
dimethyl sulfoxide

: {Ni(1-ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylate)2(dimethyl sulfoxide)2}*4H2O

B: 151933-03-8
{Ni(1-ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylate)2(H2O)2}

Conditions

Conditions	Yield
With NaOH; H2O In dimethyl sulfoxide mixing DMSO soln. of cinoxacin and of the Ni salt, slow addn. of 5 ml of aq. NaOH with stirring, crystn. of Ni(cinoxacinate)2*2H2O after 1 d; filtration, washing (water), drying at 90°C, crystn. of the Ni complex contg. dimethyl sulfoxide ligands after 2-3 months from the remaining soln., filtration, drying at room temp., elem. anal.;	A 10% B 80%

...Expand

: 28657-80-9
cinoxacin

: 95-14-7
1,2,3-Benzotriazole

: 1173208-74-6
3-(1H-benzo[d][1,2,3]triazole-1-carbonyl)-1-ethyl-[1,3]dioxolo[4,5-g]cinnolin-4(1H)-one

Conditions

Conditions	Yield
Stage #1: 1,2,3-Benzotriazole With thionyl chloride In dichloromethane at 25℃; for 0.5h; Stage #2: cinoxacin In dichloromethane at 25℃; for 2h;	80%

: 28657-80-9
cinoxacin

: 67-68-5
dimethyl sulfoxide

: 7646-85-7
zinc(II) chloride

A: {Zn(1-ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylate)2}*4H2O

: {Zn(1-ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylate)2(dimethyl sulfoxide)2}*4H2O

Conditions

Conditions	Yield
With NaOH; H2O In dimethyl sulfoxide mixing of a DMSO soln. of cinoxacin and of ZnCl2, addn. of 1 ml of aq. NaOH with stirring, pptn. of Zn(cinoxacinate)2*4H2O after 12-14 d; filtration, washing (water), drying at 90°C, remaining soln. standing at room temp., crystn. of the Zn complex (contg. additionally DMSO ligands) after a few d, filtration, drying at room temp., elem. anal.;	A 75% B 6%

...Expand

: 28657-80-9
cinoxacin

: 1429439-48-4
1-ethyl-5-nitro-4-oxo-1,4-dihydro-[1,3]dioxolo[4,5-g]cinnolin-3-carboxylic acid

Conditions

Conditions	Yield
With sulfuric acid; potassium nitrate at 0 - 20℃; for 13h; Inert atmosphere;	75%

: 28657-80-9
cinoxacin

: 67-56-1
methanol

: 1429438-89-0
methyl 1-ethyl-6,7-dihydroxy-4-oxo-1,4-dihydrocinnolin-3-carboxylate

Conditions

Conditions	Yield
Stage #1: cinoxacin With boron tribromide In dichloromethane at -30 - 20℃; for 41h; Inert atmosphere; Stage #2: methanol In dichloromethane at -30 - 20℃; Inert atmosphere;	74.5%

: 28657-80-9
cinoxacin

A: 109773-20-8
1-Ethyl-1H-[1,3]dioxolo[4,5-g]cinnolin-4-one

B: 1-Ethyl-3-hydroxy-1H-[1,3]dioxolo[4,5-g]cinnolin-4-one

Conditions

Conditions	Yield
With oxygen In methanol for 12h; Ambient temperature; Irradiation; in PBS-solution (pH=8); Yields of byproduct given;	A n/a B 62%
With oxygen In methanol for 12h; Mechanism; Product distribution; Ambient temperature; Irradiation; Iin PBS-solution (pH=8);
With oxygen In methanol for 12h; Ambient temperature; Irradiation; in PBS-solution (pH=8); Yields of byproduct given;	A 0.580 mol B n/a

: 28657-80-9
cinoxacin

5'-monomethoxytrityl-protected 5'-amino-5'-deoxythymidine phosphoramidite: 5'-monomethoxytrityl-protected 5'-amino-5'-deoxythymidine phosphoramidite

dGdCdGdCdA-resin: dGdCdGdCdA-resin

: cinoxacin 5'-amino-5'-deoxydTdGdCdGdCdA

Conditions

Conditions	Yield
Multistep reaction.;	55%

...Expand

: 28657-80-9
cinoxacin

: 52462-29-0
[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2

: 7732-18-5
water

: 108-88-3
toluene

: chlorido(η6-p-cymene)(cinoxacinato-κ2O,O')ruthenium(II)*water*0.5toluene

Conditions

Conditions	Yield
With NaOCH3 In methanol; chloroform byproducts: NaCl; addn. of sodium methylate to soln. of ruthenium compd. and sodium nalidixicate in CHCl3/methanol (1/1), refluxing for 6 h; filtration through celite, addn. of toluene, keeping at room temp. with slow evapn. for 3 d, isolation of crystals, washing with hexane, elem. anal.;	55%

...Expand

: 28657-80-9
cinoxacin

: 28657-79-6
1-ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carbonitrile

Conditions

Conditions	Yield
Stage #1: cinoxacin With polyphosphate ester; ammonia In chloroform at 119 - 123℃; for 24h; Stage #2: With polyphosphate ester at 120℃; for 1h;	21%

: 28657-80-9
cinoxacin

: aqueous cadmium chloride

: 67-68-5
dimethyl sulfoxide

: {Cd2(1-ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-caboxylate)4(DMSO)2} * 2H2O

Conditions

Conditions	Yield
With NaOH In dimethyl sulfoxide mixing DMSO solns. of cinoxacin (0.4 mmol) and CdCl2*2.5H2O (0.1 mmol); slow addn. of NaOH (0.1 M) with continuous stirring;; slow evapn. at room temp.; crystn. after 2-3 mo; elem. anal.;;	12%

...Expand

: 28657-80-9
cinoxacin

: 67124-17-8
5-ethyl-5H-[1,3]dioxolo[4,5-f]indole-6,7-dione

Conditions

Conditions	Yield
In formic acid; water (electrochemical reduction);

: 28657-80-9
cinoxacin

: 156-57-0
2-mercaptoethylamine hydrochloride

: 86222-61-9
1-Ethyl-N-(2-mercaptoethyl)-6,7-methylene-dioxy-4(1H)-oxocinnoline-3-carboxamide

Conditions

Conditions	Yield
With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide

: 28657-80-9
cinoxacin

: 86222-62-0
1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid, methyl ester

Conditions

Conditions	Yield
With sodium hydrogencarbonate In methanol; water

: 28657-80-9
cinoxacin

: cobalt(II) perchlorate hexahydrate

: sodium tris(1-ethyl-4(1H)-oxo-(1,3)dioxolo(4,5-g)cinnoline-3-carboxylato)cobaltate(II)*10H2O

Conditions

Conditions	Yield
With sodium hydroxide In water; dimethyl sulfoxide Co(ClO4)2*6H2O mixed with cinoxacin; soln. NaOH added with stirring for1 h; filtered; washed (DMSO); dreid in vac. at 50°C to const. wt.; elem. anal.; powd. XRD; TG-DTA;

: 28657-80-9
cinoxacin

: copper(II) nitrate trihydrate

: bis(1-ethyl-4(1H)-oxo-(1,3)dioxolo(4,5-g)cinnoline-3-carboxylato)copper(II) hydrate

Conditions

Conditions	Yield
With sodium hydroxide In water; dimethyl sulfoxide cinoxacin mixed with Cu(NO3)2*3H2O; NaOH added with stirring; ppt. filtered; washed (DMSO); dried in vac. at 50°C; elem. anal.; powd. XRD, TG-DTA;

: 28657-80-9
cinoxacin

: nickel(II) perchlorate hexahydrate

: tris(1-ethyl-4(1H)-oxo-(1,3)dioxolo(4,5-g)cinnoline-3-carboxylato)dinickel(II) perchlorate octahydrate

Conditions

Conditions	Yield
With sodium hydroxide In methanol; water cinoxacin mixed with Ni(ClO4)2*6H2O; NaOH added with stirring; evapn. at room temp. for several d; filtered; washed (methanol); dried in vac. at 50°C; elem. anal.; powd. XRD, TG-DTA;

: 28657-80-9
cinoxacin

: copper(II) nitrate trihydrate

: 51-45-6
histamine

A: 186689-97-4
[Cu(cinoxacinate)2]

: [Cu(histamine)(cinoxacinate)NO3]H2O

Conditions

Conditions	Yield
With NaOH In ethanol; water addn. of freshly prepared soln. of histamine in ethanol to aq. soln. of copper salt, addn. of an aq. soln. of cinoxacin with NaOH; cooling overnight, filtration, cooling filtrate in refrigerator for 7- 8months; elem. anal.;

...Expand

: 28657-80-9
cinoxacin

: copper dichloride

: aquachloro(1-ethyl-1,4-dihydro-4-oxo-1,3-dioxolo[4,5-g]cinnoline-3-carboxylato-O(3),O(4))(1-ethyl-1,4-dihydro-4-oxo-1,3-dioxolo[4,5-g]cinnoline-3-carboxylic acid-O(3),O(4))copper(II)

Conditions

Conditions	Yield
In methanol stoich. amts., warm solvent; pptn. on standing for few d, collection (filtration); single crystals fro mother liquor on slow evapn.;

: 28657-80-9
cinoxacin

: C119H147N34O53P8Pol

: C131H155N36O57P8Pol

Conditions

Conditions	Yield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide

: 28657-80-9
cinoxacin

: 1429438-94-7
1-ethyl-6,7-bis((4-methoxybenzyl)oxy)-3-(pyrrolidin-1-ylmethyl)cinnolin-4(1H)-one

Conditions

Conditions	Yield
Multi-step reaction with 6 steps 1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere 1.2: -30 - 20 °C / Inert atmosphere 2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux 3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux 3.2: 20 °C / pH 1 / Inert atmosphere 4.1: chloroformic acid ethyl ester; triethylamine / tetrahydrofuran / 2 h / 20 °C / Inert atmosphere 4.2: 2 h / 20 °C / Inert atmosphere 5.1: Dess-Martin periodane / dichloromethane / 1 h / 20 °C / Inert atmosphere 6.1: sodium tris(acetoxy)borohydride; acetic acid / 1,2-dichloro-ethane / 1.5 h / 20 °C / Inert atmosphere View Scheme

Yield

Multi-step reaction with 6 steps
1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere
1.2: -30 - 20 °C / Inert atmosphere
2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux
3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux
3.2: 20 °C / pH 1 / Inert atmosphere
4.1: chloroformic acid ethyl ester; triethylamine / tetrahydrofuran / 2 h / 20 °C / Inert atmosphere
4.2: 2 h / 20 °C / Inert atmosphere
5.1: Dess-Martin periodane / dichloromethane / 1 h / 20 °C / Inert atmosphere
6.1: sodium tris(acetoxy)borohydride; acetic acid / 1,2-dichloro-ethane / 1.5 h / 20 °C / Inert atmosphere
View Scheme

: 28657-80-9
cinoxacin

: C27H25ClN2O6

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere 1.2: -30 - 20 °C / Inert atmosphere 2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux 3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux 3.2: 20 °C / pH 1 / Inert atmosphere 4.1: thionyl chloride / dichloromethane / 1 h / Inert atmosphere; Reflux View Scheme

Yield

Multi-step reaction with 4 steps
1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere
1.2: -30 - 20 °C / Inert atmosphere
2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux
3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux
3.2: 20 °C / pH 1 / Inert atmosphere
4.1: thionyl chloride / dichloromethane / 1 h / Inert atmosphere; Reflux
View Scheme

: 28657-80-9
cinoxacin

: 1429438-99-2
1-ethyl-6,7-bis((4-methoxybenzyl)oxy)-4-oxo-N-(2-(pyrrolidin-1-yl)ethyl)-1,4-dihydrocinnolin-3-carboxamide

Conditions

Conditions	Yield
Multi-step reaction with 5 steps 1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere 1.2: -30 - 20 °C / Inert atmosphere 2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux 3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux 3.2: 20 °C / pH 1 / Inert atmosphere 4.1: thionyl chloride / dichloromethane / 1 h / Inert atmosphere; Reflux 5.1: triethylamine / dichloromethane / 0.5 h / 20 °C / Cooling with ice View Scheme

Yield

Multi-step reaction with 5 steps
1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere
1.2: -30 - 20 °C / Inert atmosphere
2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux
3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux
3.2: 20 °C / pH 1 / Inert atmosphere
4.1: thionyl chloride / dichloromethane / 1 h / Inert atmosphere; Reflux
5.1: triethylamine / dichloromethane / 0.5 h / 20 °C / Cooling with ice
View Scheme

: 28657-80-9
cinoxacin

: 1429439-01-9
1-ethyl-6,7-bis((4-methoxybenzyl)oxy)-3-(piperidin-1-ylmethyl)cinnolin-4(1H)-one

Conditions

Conditions	Yield
Multi-step reaction with 5 steps 1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere 1.2: -30 - 20 °C / Inert atmosphere 2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux 3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux 3.2: 20 °C / pH 1 / Inert atmosphere 4.1: chloroformic acid ethyl ester; triethylamine / tetrahydrofuran / 2 h / 20 °C / Inert atmosphere 4.2: 2 h / 20 °C / Inert atmosphere 5.1: methanesulfonyl chloride; triethylamine / dichloromethane / 2 h / Cooling with ice; Inert atmosphere 5.2: Inert atmosphere View Scheme

Yield

Multi-step reaction with 5 steps
1.1: boron tribromide / dichloromethane / 41 h / -30 - 20 °C / Inert atmosphere
1.2: -30 - 20 °C / Inert atmosphere
2.1: potassium carbonate; potassium iodide / acetone / Inert atmosphere; Reflux
3.1: potassium hydroxide / methanol; water / 1.5 h / Inert atmosphere; Reflux
3.2: 20 °C / pH 1 / Inert atmosphere
4.1: chloroformic acid ethyl ester; triethylamine / tetrahydrofuran / 2 h / 20 °C / Inert atmosphere
4.2: 2 h / 20 °C / Inert atmosphere
5.1: methanesulfonyl chloride; triethylamine / dichloromethane / 2 h / Cooling with ice; Inert atmosphere
5.2: Inert atmosphere
View Scheme

: 28657-80-9
cinoxacin

: 1429439-49-5
5-amino-1-ethyl-4-oxo-1,4-dihydro-[1,3]dioxolo[4,5-g]cinnolin-3-carboxylic acid

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: sulfuric acid; potassium nitrate / 13 h / 0 - 20 °C / Inert atmosphere 2: hydrogenchloride; palladium on activated charcoal; hydrogen; acetic acid / 5 h / 2585.81 Torr / Inert atmosphere View Scheme

: 28657-80-9
cinoxacin

: 1429439-50-8
3-carboxy-1-ethyl-4-oxo-1,4-dihydro-[1,3]dioxolo[4,5-g]cinnolin-5-diazonium chloride

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1: sulfuric acid; potassium nitrate / 13 h / 0 - 20 °C / Inert atmosphere 2: hydrogenchloride; palladium on activated charcoal; hydrogen; acetic acid / 5 h / 2585.81 Torr / Inert atmosphere 3: hydrogenchloride; sodium nitrite / water / 5 h / 45 °C / Inert atmosphere View Scheme

: 28657-80-9
cinoxacin

: 1429439-51-9
5-chloro-1-ethyl-6,7-dihydroxy-4-oxo-1,4-dihydrocinnolin-3-carboxylic acid

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: sulfuric acid; potassium nitrate / 13 h / 0 - 20 °C / Inert atmosphere 2: hydrogenchloride; palladium on activated charcoal; hydrogen; acetic acid / 5 h / 2585.81 Torr / Inert atmosphere 3: hydrogenchloride; sodium nitrite / water / 5 h / 45 °C / Inert atmosphere 4: sulfuric acid / 20 h / 95 °C / Inert atmosphere View Scheme

CINOXACIN Chemical Properties

Product Name: Cinoxacin (CAS NO.28657-80-9)

Molecular Formula: C₁₂H₁₀N₂O₅
Molecular Weight: 262.22g/mol
Mol File: 28657-80-9.mol
Einecs: 249-133-8
Appearance: Light tan crystals
Boiling point: 517.2 °C at 760 mmHg
Density: 1.64 g/cm³
Surface Tension: 65.7 dyne/cm
Enthalpy of Vaporization: 83.11 kJ/mol
Vapour Pressure: 1.61E-11 mmHg at 25°C
XLogP3-AA: 2.1
H-Bond Donor: 1
H-Bond Acceptor: 7
Product Categories: Interferes with DNA SynthesisAntibiotics; Quinolones and FluoroquinolonesMore...Close...; A - KAntibiotics; Antibacterial; Antibiotics A to; Antibiotics A-FAntibiotics; Antibiotics by Application; Antineoplastic and Immunosuppressive AntibioticsAntibiotics; Chemical Structure Class; Inhibits an EnzymeAntibiotics; Mechanism of Action; Spectrum of Activity

CINOXACIN Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intravenous	850mg/kg (850mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Chemotherapy Vol. 28(Suppl,
mouse	LD50	oral	2330mg/kg (2330mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Chemotherapy Vol. 28(Suppl,
mouse	LD50	subcutaneous	900mg/kg (900mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Chemotherapy Vol. 28(Suppl,
rat	LD50	intravenous	860mg/kg (860mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Chemotherapy Vol. 28(Suppl,
rat	LD50	oral	3610mg/kg (3610mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Chemotherapy Vol. 28(Suppl,
rat	LD50	subcutaneous	1380mg/kg (1380mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Chemotherapy Vol. 28(Suppl,

CINOXACIN Safety Profile

Moderately toxic by ingestion, subcutaneous and intravenous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NO_x.

CINOXACIN Specification

Cinoxacin ,its CAS NO. is 28657-80-9,the synonyms is 1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid;cinoxacin ; Timtec-bb sbb003082 ; 1-Ethyl-6,7-methylenedioxy-4(1h)-oxocinnoline-3-carboxylicacid ; 3)Dioxolo(4,5-g)cinnoline-3-carboxylicacid,1,4-dihydro-1-ethyl-4-oxo-( ; Cinobac ; 1-Ethyl-4-oxo-1,4-dihydro-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid .

Product Name

CINOXACIN

Synthetic route

CINOXACIN Chemical Properties

CINOXACIN Toxicity Data With Reference

CINOXACIN Safety Profile

CINOXACIN Specification

Related Products

Hot Products